Skip to main content
Top
Published in: Rheumatology International 2/2013

01-02-2013 | Original Article

Association of MMP-3 (-1612 5A/6A) polymorphism with knee osteoarthritis in Thai population

Authors: Sittisak Honsawek, Somkiat Malila, Pongsak Yuktanandana, Aree Tanavalee, Benjamad Deepaisarnsakul, Javad Parvizi

Published in: Rheumatology International | Issue 2/2013

Login to get access

Abstract

Osteoarthritis (OA) is a degenerative joint disorder resulting in destruction of articular cartilage, osteophyte formation, and subchondral bone sclerosis. In recent years, numerous genetic factors have been identified and implicated in causing osteoarthritis. One such genetic defect is a single nucleotide polymorphism at position -1612 of matrix metalloproteinase-3 (MMP-3) promoter region, known to lead to three possible genotypes, 5A/5A, 6A/6A, and 5A/6A. The purpose of this study was to investigate the association of MMP-3 -1612 5A/6A gene polymorphism with knee osteoarthritis in Thai population. Genotype distributions and allelic frequencies of MMP-3 -1612 5A/6A polymorphism were investigated in 200 participants (100 patients with knee osteoarthritis and 100 healthy controls). Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism. There was no statistically significant difference between the groups with respect to genotype distribution (P > 0.05). The 5A allele frequency was indicated as 15.5 %, and 6A allele was as 84.5 % in OA patients, whereas it was 10–90 % in the control group. Accordingly, the present study has indicated that the -1612 5A/6A polymorphism genotypes of MMP-3 gene promoter do not play a role in the development of osteoarthritis in the Thai population.
Literature
1.
go back to reference Krasnokutsky S, Attur M, Palmer G et al (2008) Current concepts in the pathogenesis of osteoarthritis. Osteoarthritis Cartilage 16S:1–3CrossRef Krasnokutsky S, Attur M, Palmer G et al (2008) Current concepts in the pathogenesis of osteoarthritis. Osteoarthritis Cartilage 16S:1–3CrossRef
2.
go back to reference Banks SE (2010) Erosive osteoarthritis: a current review of a clinical challenge. Clin Rheumatol 29:697–706PubMedCrossRef Banks SE (2010) Erosive osteoarthritis: a current review of a clinical challenge. Clin Rheumatol 29:697–706PubMedCrossRef
3.
go back to reference Loeser RF (2009) Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage 17:971–979PubMedCrossRef Loeser RF (2009) Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage 17:971–979PubMedCrossRef
4.
go back to reference Steinmeyer J (2004) Cytokines in osteoarthritis-current status on the pharmacological intervention. Front Biosci 9:575–580PubMedCrossRef Steinmeyer J (2004) Cytokines in osteoarthritis-current status on the pharmacological intervention. Front Biosci 9:575–580PubMedCrossRef
5.
go back to reference Keen RW, Hart DJ, Lanchbury JS, Spector TD (1997) Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene. Arthritis Rheum 40:1444–1449PubMedCrossRef Keen RW, Hart DJ, Lanchbury JS, Spector TD (1997) Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene. Arthritis Rheum 40:1444–1449PubMedCrossRef
6.
go back to reference Bergink AP, van Meurs JB, Loughlin J et al (2003) Estrogen receptor alpha gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women. Arthritis Rheum 48:1913–1922PubMedCrossRef Bergink AP, van Meurs JB, Loughlin J et al (2003) Estrogen receptor alpha gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women. Arthritis Rheum 48:1913–1922PubMedCrossRef
7.
go back to reference Magaña JJ, Gálvez-Rosas A, González-Huerta C et al (2010) Association of the calcitonin gene (CA) polymorphism with osteoarthritis of the knee in a Mexican mestizo population. Knee 17:157–160PubMedCrossRef Magaña JJ, Gálvez-Rosas A, González-Huerta C et al (2010) Association of the calcitonin gene (CA) polymorphism with osteoarthritis of the knee in a Mexican mestizo population. Knee 17:157–160PubMedCrossRef
8.
go back to reference Valdes AM, Arden NK, Tamm A et al (2010) A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis. Osteoarthritis Cartilage 18:699–704PubMedCrossRef Valdes AM, Arden NK, Tamm A et al (2010) A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis. Osteoarthritis Cartilage 18:699–704PubMedCrossRef
9.
go back to reference Valdes AM, Spector TD, Tamm A et al (2010) Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum 62:2347–2352PubMedCrossRef Valdes AM, Spector TD, Tamm A et al (2010) Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum 62:2347–2352PubMedCrossRef
10.
go back to reference Barlas IO, Sezgin M, Erdal ME et al (2009) Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int 29:383–388PubMedCrossRef Barlas IO, Sezgin M, Erdal ME et al (2009) Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int 29:383–388PubMedCrossRef
11.
go back to reference Murphy G, Docherty AJ (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120–125PubMed Murphy G, Docherty AJ (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120–125PubMed
12.
go back to reference Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ (1997) Matrix metalloproteinases. Br J Surg 84:160–166PubMedCrossRef Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ (1997) Matrix metalloproteinases. Br J Surg 84:160–166PubMedCrossRef
13.
go back to reference Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174PubMedCrossRef Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174PubMedCrossRef
14.
go back to reference Inoue K, Masuko-Hongo K, Okamoto M, Nishioka K (2005) Induction of vascular endothelial growth factor and matrix metalloproteinase-3 (stromelysin) by interleukin-1 in human articular chondrocytes and synoviocytes. Rheumatol Int 26:93–98PubMedCrossRef Inoue K, Masuko-Hongo K, Okamoto M, Nishioka K (2005) Induction of vascular endothelial growth factor and matrix metalloproteinase-3 (stromelysin) by interleukin-1 in human articular chondrocytes and synoviocytes. Rheumatol Int 26:93–98PubMedCrossRef
15.
go back to reference Arthur MJ (2000) Fibrogenesis II metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279:G245–G249PubMed Arthur MJ (2000) Fibrogenesis II metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279:G245–G249PubMed
16.
go back to reference Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154PubMed Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154PubMed
17.
go back to reference Nagase H, Suzuki K, Morodomi T, Enghild JJ, Salvesen G (1992) Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix Suppl 1:237–244PubMed Nagase H, Suzuki K, Morodomi T, Enghild JJ, Salvesen G (1992) Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix Suppl 1:237–244PubMed
18.
go back to reference Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM (1995) Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 73:209–215PubMedCrossRef Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM (1995) Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 73:209–215PubMedCrossRef
19.
go back to reference Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271:13055–13060PubMedCrossRef Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271:13055–13060PubMedCrossRef
20.
go back to reference Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502PubMedCrossRef Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502PubMedCrossRef
21.
go back to reference Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests. Scand J Rheumatol Suppl 65:85–89PubMedCrossRef Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests. Scand J Rheumatol Suppl 65:85–89PubMedCrossRef
22.
go back to reference Dunleavey L, Beyzade S, Ye S (2000) Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 151:587–589PubMedCrossRef Dunleavey L, Beyzade S, Ye S (2000) Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 151:587–589PubMedCrossRef
23.
go back to reference Zhu C, Odeberg J, Hamsten A, Eriksson P (2006) Allele-specific MMP-3 transcription under in vivo conditions. Biochem Biophys Res Commun 348:1150–1156PubMedCrossRef Zhu C, Odeberg J, Hamsten A, Eriksson P (2006) Allele-specific MMP-3 transcription under in vivo conditions. Biochem Biophys Res Commun 348:1150–1156PubMedCrossRef
24.
go back to reference Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125PubMedCrossRef Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125PubMedCrossRef
25.
go back to reference Wassilew GI, Lehnigk U, Duda GN, Taylor WR, Matziolis G, Dynybil C (2010) The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders. Arthroscopy 26:1096–1104PubMedCrossRef Wassilew GI, Lehnigk U, Duda GN, Taylor WR, Matziolis G, Dynybil C (2010) The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders. Arthroscopy 26:1096–1104PubMedCrossRef
26.
go back to reference Bobacz K, Maier R, Fialka C et al (2003) Is pro-matrix metalloproteinase-3 a marker for posttraumatic cartilage degradation? Osteoarthritis Cartilage 11:665–672PubMedCrossRef Bobacz K, Maier R, Fialka C et al (2003) Is pro-matrix metalloproteinase-3 a marker for posttraumatic cartilage degradation? Osteoarthritis Cartilage 11:665–672PubMedCrossRef
27.
go back to reference Ye S, Patodi N, Walker-Bone K, Reading I, Cooper C, Dennison E (2007) Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid arthritis. Int J Immunogenet 34:81–85PubMedCrossRef Ye S, Patodi N, Walker-Bone K, Reading I, Cooper C, Dennison E (2007) Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid arthritis. Int J Immunogenet 34:81–85PubMedCrossRef
28.
go back to reference Abd-Allah SH, Shalaby SM, Pasha HF, El-Shal AS, Abou El-Saoud AM (2011) Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis. Genet Test Mol Biomarkers. doi:10.1089/gtmb.2011.0003 PubMed Abd-Allah SH, Shalaby SM, Pasha HF, El-Shal AS, Abou El-Saoud AM (2011) Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis. Genet Test Mol Biomarkers. doi:10.​1089/​gtmb.​2011.​0003 PubMed
29.
go back to reference Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH (2004) Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 5:147–149PubMedCrossRef Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH (2004) Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 5:147–149PubMedCrossRef
Metadata
Title
Association of MMP-3 (-1612 5A/6A) polymorphism with knee osteoarthritis in Thai population
Authors
Sittisak Honsawek
Somkiat Malila
Pongsak Yuktanandana
Aree Tanavalee
Benjamad Deepaisarnsakul
Javad Parvizi
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2371-y

Other articles of this Issue 2/2013

Rheumatology International 2/2013 Go to the issue